Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Supply disruption expected for Evorel 75 & 50

There will be intermittent supply of Evorel 75 and Evorel 50 during the first half of this month following unprecedented demand, drug manufacturer Theramex said on Friday (July 3).

Other products in Evorel portfolio, Evorel 25, Evorel 100, Evorel Conti and Evorel Sequi are all currently available in market.


CountryProduct NameDates of Availability
UK
  1. Evorel 25
  2. Evorel 50
  3. Evorel 75
  4. Evorel 100
  5. Evorel Conti
  6. EvorelSequi
  1. Available
  2. Intermittent supply first half of July
  3. Intermittent supply first half of July
  4. Available
  5. Available
  6. Available
 

“Since February 2020, we have produced nearly 750,000 packs across the Evorel portfolio. There has been unprecedented demand for all of the products and we are are working with our manufacturing partners to continuously increase capacity in order to ensure that Evorel is readily available to every patient who needs it,” the London-based drug maker noted.

In order to ensure the widest possible reach of the available stock, pharmacists have been informed that Alliance Healthcare have applied monthly quotas to the volume of stock available to individual pharmacists.

If any pharmacy requires additional stock on the quota to fulfill prescriptions, the pharmacists can reach Alliance Healthcare customer service, the company added.